Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Iron-carbon (Fe/C) nanoparticles, also referred to as SPINs in research contexts, are magnetic nanoparticles engineered for magnetic hyperthermia-based cancer therapy. These nanoparticles are synthesized using a co-precipitation method with optimized precursor ratios to achieve a high saturation magnetization (e.g., 148.6 emu/g). The therapeutic mechanism involves the intratumoral administration of the nanoparticles followed by exposure to an alternating magnetic field (AMF). The AMF causes the nanoparticles to generate localized heat, which induces thermal-mediated cell death (hyperthermia) in the tumor tissue. Preclinical studies in breast cancer (MCF-7) and prostate cancer (DU145) xenograft models have demonstrated that these nanoparticles can induce significant tumor reduction and near-complete regression, depending on the dosage and field exposure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on iron-carbon nanoparticles.